Stockscreener 앱 받기
23.51
0.21%
0.05
시간 외 거래:
23.40
-0.11
-0.47%
Bicycle Therapeutics Plc Adr 주식(BCYC)의 최신 뉴스
Bicycle Therapeutics' SWOT analysis: stock's potential rides on innovative platform - Investing.com India
Bicycle Therapeutics spotlights cancer treatment targets - Investing.com
Bicycle Therapeutics (BCYC) Soars 5.7%: Is Further Upside Left in the Stock? - MSN
A company insider recently sold 3,212 shares of Bicycle Therapeutics Plc ADR [BCYC]. Should You also Consider to Sale? – Knox Daily - Knox Daily
BCYC’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - The InvestChronicle
Keeping an Eye on Bicycle Therapeutics Plc ADR (BCYC) After Insider Trading Activity - Knox Daily
Bicycle Therapeutics Plc ADR (BCYC)’s stock price range in the last year - US Post News
Bicycle therapeutics executive sells shares worth over $21k - Investing.com India
Bicycle therapeutics executive sells shares to cover tax obligations - Investing.com India
Bicycle therapeutics COO sells shares worth over $21k - Investing.com India
Bicycle therapeutics CEO sells shares worth over $71k - Investing.com
Bicycle therapeutics CTO sells shares worth over $21k - Investing.com
Bicycle therapeutics executive sells shares worth over $5,000 - Investing.com
CHIEF PROD & SUPPLY CHAIN OFF Hannay Michael Charles Ferguso sale 246 shares of Bicycle Therapeutics Plc ADR [BCYC] – Knox Daily - Knox Daily
Bicycle Therapeutics Plc ADR (BCYC)’s stock chart: A technical perspective - US Post News
Market Update: Bicycle Therapeutics Plc ADR (BCYC) Sees Negative Movement, Closing at 22.56 - The Dwinnex
Wall Street SWOT: Bicycle Therapeutics stock rides high on cancer drug promise - Investing.com
A company insider recently sold 246 shares of Bicycle Therapeutics Plc ADR [BCYC]. Should You Sale? - Knox Daily
Nothing is Better Than Bicycle Therapeutics Plc ADR (BCYC) stock at the moment - SETE News
RBC Capital Mkts initates Bicycle Therapeutics Plc ADR (BCYC) stock to an Outperform - Knox Daily
Metric Analysis: Bicycle Therapeutics Plc ADR (BCYC)’s Key Ratios in the Limelight - The Dwinnex
Bicycle Therapeutics Plc ADR: A Year of Highs, Lows, and Market Resilience - The InvestChronicle
Are Bicycle Therapeutics Plc ADR (BCYC) shares a good deal now? - US Post News
Hain Celestial Group Inc [HAIN] Investment Guide: What You Need to Know - Knox Daily
Bicycle Therapeutics stock maintains Buy rating post-ESMO data By Investing.com - Investing.com UK
Bicycle Therapeutics Plc ADR [BCYC] Shares Fall -0.26 % on Wednesday - Knox Daily
A stock that deserves closer examination: Bicycle Therapeutics Plc ADR (BCYC) - US Post News
Bicycle Therapeutics Plc ADR (BCYC) Stock: A 52-Week Tale of Drops and Gains - The InvestChronicle
Aqua Metals Inc [AQMS] Shares Fall Approximately -81.89% Over the Year - Knox Daily
Taking a look at what insiders are doing to gauge the Interface Inc. [TILE] - Knox Daily
Sleep Number Corp [SNBR] Director makes an insider purchase of 43,000 shares worth 0.53 million. - Knox Daily
Top investors say Bicycle Therapeutics Plc ADR (BCYC) ticks everything they need - SETE News
Bicycle Therapeutics (BCYC) Moves to Buy: Rationale Behind the Upgrade - MSN
An Analysis of Bicycle Therapeutics Plc ADR (BCYC)’s Potential Price Growth - Knox Daily
CDT Stock Earnings: Conduit Pharmaceuticals Reported Results for Q2 2024 - MSN
What Makes Bicycle Therapeutics (BCYC) a New Buy Stock - Yahoo Finance
Wall Street Analysts See an 88.94% Upside in Bicycle Therapeutics (BCYC): Can the Stock Really Move This High? - Yahoo Finance
B. Riley Securities’s latest rating for BCYC stock - Knox Daily
Bicycle Therapeutics Plc ADR (BCYC) may enjoy gains as insiders got busy in the recent days - Knox Daily
Bicycle Therapeutics Plc ADR’s latest rating changes from various analysts - Knox Daily
Bicycle Therapeutics Plc ADR [BCYC] Investment Appeal on the Rise – Knox Daily - Knox Daily
Is it a good time to sell Wendy's Co [WEN] shares after an insider sold 21000 shares? – Knox Daily - Knox Daily
Strength Seen in Bicycle Therapeutics PLC Sponsored ADR (BCYC): Can Its 5.9% Jump Turn into More Strength? - Yahoo Movies UK
Bicycle (BCYC) to Begin Pivotal Bladder Cancer Study, Stock Up - Yahoo News Malaysia
Bicycle Therapeutics PLC Sponsored ADR (BCYC) Soars 19.3%: Is Further Upside Left in the Stock? - Yahoo Sport Australia
Are Medical Stocks Lagging Bicycle Therapeutics (BCYC) This Year? - Yahoo Finance
Investing in Bicycle Therapeutics Plc ADR (BCYC) Is Getting More Attractive – Knox Daily - Knox Daily
Top 5 Small-Cap Biotechnology Stocks for a Stable Portfolio - Zacks Investment Research
Top 5 Small-Cap Biotechnology Stocks for a Stable Portfolio - Zacks Investment Research
Trading Day Review: Bicycle Therapeutics Plc ADR (BCYC) Loses Momentum, Closing at 20.75 – DWinneX - The Dwinnex
BCYC Stock on the Rise: A Promising Investment - The InvestChronicle
Bicycle Therapeutics PLC Sponsored ADR (BCYC) Stock Jumps 24.5%: Will It Continue to Soar? - Yahoo Sport Australia
Is Bicycle Therapeutics (BCYC) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Bicycle Therapeutics (BCYC) Catches Eye: Stock Jumps 8.9% - Yahoo Movies UK
Bicycle Therapeutics Plc ADR [BCYC] CHIEF PROD & SUPPLY CHAIN OFF makes an insider sale of 257 shares worth ... - Knox Daily
MSN - MSN
2.02%
0.47%
자본화:
|
볼륨(24시간):